Nami Okamoto

627 total citations
19 papers, 285 citations indexed

About

Nami Okamoto is a scholar working on Hematology, Rheumatology and Speech and Hearing. According to data from OpenAlex, Nami Okamoto has authored 19 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Rheumatology and 5 papers in Speech and Hearing. Recurrent topics in Nami Okamoto's work include Autoimmune and Inflammatory Disorders Research (9 papers), Adolescent and Pediatric Healthcare (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Nami Okamoto is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (9 papers), Adolescent and Pediatric Healthcare (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Nami Okamoto collaborates with scholars based in Japan, Iran and United States. Nami Okamoto's co-authors include Hiroshi Tamai, Masaaki Mori, Hiroaki Umebayashi, Naomi Iwata, Takuji Murata, Hiroichi Nagai, Hiroyuki Tanaka, Masaki Shimizu, Tomohiro Kubota and Yuka Okura and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Care & Research and International Archives of Allergy and Immunology.

In The Last Decade

Nami Okamoto

17 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nami Okamoto Japan 11 153 72 63 48 47 19 285
Kathy de Graaf Switzerland 7 207 1.4× 209 2.9× 48 0.8× 58 1.2× 82 1.7× 8 418
Leila Emma D’Urbano Italy 7 177 1.2× 198 2.8× 31 0.5× 67 1.4× 96 2.0× 8 436
G. Elizabeth Legger Netherlands 8 70 0.5× 50 0.7× 21 0.3× 28 0.6× 31 0.7× 14 176
Nancy Pan United States 9 95 0.6× 90 1.3× 84 1.3× 39 0.8× 23 0.5× 19 254
Dong Ho Nahm South Korea 11 153 1.0× 124 1.7× 55 0.9× 12 0.3× 73 1.6× 23 401
Melissa Tesher United States 8 82 0.5× 57 0.8× 30 0.5× 16 0.3× 13 0.3× 19 180
Thuan-Chong Quah Singapore 8 56 0.4× 100 1.4× 31 0.5× 23 0.5× 40 0.9× 12 345
Sirirat Charuvanij Thailand 10 99 0.6× 24 0.3× 67 1.1× 40 0.8× 37 0.8× 33 192
Tatjana Welzel Switzerland 11 65 0.4× 80 1.1× 39 0.6× 12 0.3× 126 2.7× 37 292
Heidi Lausten Munk Denmark 9 50 0.3× 85 1.2× 113 1.8× 7 0.1× 109 2.3× 21 307

Countries citing papers authored by Nami Okamoto

Since Specialization
Citations

This map shows the geographic impact of Nami Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nami Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nami Okamoto more than expected).

Fields of papers citing papers by Nami Okamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nami Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nami Okamoto. The network helps show where Nami Okamoto may publish in the future.

Co-authorship network of co-authors of Nami Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Nami Okamoto. A scholar is included among the top collaborators of Nami Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nami Okamoto. Nami Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Okamoto, Nami, Tatsuya Atsumi, Michiaki Takagi, et al.. (2024). Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study. Modern Rheumatology. 35(2). 215–224. 6 indexed citations
2.
Kishi, Takayuki, Naoko Nakano, Hidehiko Narazaki, et al.. (2023). Survey of diversity awareness and environment among members of the Pediatric Rheumatology Association of Japan. Pediatrics International. 65(1). e15654–e15654.
3.
Shimizu, Masaki, Kenichi Nishimura, Naomi Iwata, et al.. (2023). Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan. International Journal of Rheumatic Diseases. 26(5). 938–945. 2 indexed citations
4.
Takagi, Michiaki, Tatsuya Atsumi, Hiroaki Matsuno, et al.. (2022). Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance. Modern Rheumatology. 33(4). 647–656. 17 indexed citations
5.
Fujii, Takao, Tatsuya Atsumi, Nami Okamoto, et al.. (2021). AB0249 SAFETY OF BARICITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA): THE 2020 INTERIM REPORT FROM ALL-CASE POST MARKETING SURVEILLANCE IN CLINICAL PRACTICE. Annals of the Rheumatic Diseases. 80. 1150–1150. 6 indexed citations
6.
Tomiita, Minako, Ichiro Kobayashi, Yasuhiko Itoh, et al.. (2020). Clinical practice guidance for Sjögren’s syndrome in pediatric patients (2018) – summarized and updated. Modern Rheumatology. 31(2). 283–293. 11 indexed citations
7.
Iwata, Naomi, Minako Tomiita, Ichiro Kobayashi, et al.. (2020). Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study. Pediatric Rheumatology. 18(1). 73–73.
8.
Shimizu, Masaki, Mao Mizuta, Nami Okamoto, et al.. (2020). Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Pediatric Rheumatology. 18(1). 2–2. 32 indexed citations
9.
Yashiro, Masato, Nami Okamoto, Hiroaki Umebayashi, et al.. (2019). Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ). Pediatric Rheumatology. 17(1). 15–15. 23 indexed citations
10.
Hara, Ryoki, Hiroaki Umebayashi, Syuji Takei, et al.. (2019). Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study. Pediatric Rheumatology. 17(1). 17–17. 10 indexed citations
11.
Shimizu, Masaki, Mao Mizuta, Takahiro Yasumi, et al.. (2019). AB1050 TOCILIZUMAB MODIFIES CLINICAL MANIFESTATIONS AND LABORATORY FEATURES OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED MACROPHAGE ACTIVATION SYNDROME. Annals of the Rheumatic Diseases. 78. 1989–1989. 3 indexed citations
12.
Mimura, Toshihide, Yuya Kondo, Akihide Ohta, et al.. (2018). Evidence-based clinical practice guideline for adult Still’s disease. Modern Rheumatology. 28(5). 736–757. 45 indexed citations
13.
Okamoto, Nami, Shumpei Yokota, Syuji Takei, et al.. (2018). Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018. Modern Rheumatology. 29(1). 41–59. 32 indexed citations
14.
Tanaka, Takayuki, Ryuta Nishikomori, Hidemasa Sakai, et al.. (2018). National survey of Japanese patients with mevalonate kinase deficiency reveals distinctive genetic and clinical characteristics. Modern Rheumatology. 29(1). 181–187. 13 indexed citations
15.
16.
Shimizu, Masaki, Mao Mizuta, Takahiro Yasumi, et al.. (2017). Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis. Arthritis Care & Research. 70(9). 1412–1415. 14 indexed citations
17.
Murata, Takuji, Nami Okamoto, Toshio Shimizu, & Hiroshi Tamai. (2007). Diagnosis and Management of Periodic fever with Aphtous Pharyngitis and Adenitis (PFAPA). Japanese Journal of Clinical Immunology. 30(2). 101–107. 3 indexed citations
18.
Hara, Keita, et al.. (2006). Febrile seizures associated with influenza A. Brain and Development. 29(1). 30–38. 24 indexed citations
19.
Okamoto, Nami, Takuji Murata, Hiroshi Tamai, Hiroyuki Tanaka, & Hiroichi Nagai. (2006). Effects of Alpha Tocopherol and Probucol Supplements on Allergen-Induced Airway Inflammation and Hyperresponsiveness in a Mouse Model of Allergic Asthma. International Archives of Allergy and Immunology. 141(2). 172–180. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathy de Graaf Breakdown of academic impact, for papers by Leila Emma D’Urbano Breakdown of academic impact, for papers by G. Elizabeth Legger Breakdown of academic impact, for papers by Nancy Pan Breakdown of academic impact, for papers by Dong Ho Nahm Breakdown of academic impact, for papers by Melissa Tesher Breakdown of academic impact, for papers by Thuan-Chong Quah Breakdown of academic impact, for papers by Sirirat Charuvanij Breakdown of academic impact, for papers by Tatjana Welzel Breakdown of academic impact, for papers by Heidi Lausten Munk
Rankless by CCL
2026